Cargando…
Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
BACKGROUND: Diabetes patients presenting with ST-segment elevation myocardial infarction (STEMI) scheduled for primary percutaneous coronary intervention (PCI) have an increased risk of contrast induced-acute kidney injury (CI-AKI). The effects of continuous use of metformin on kidney function are s...
Autores principales: | Yu, Qi, Zhu, Jia-Jia, Liu, Wen-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175536/ https://www.ncbi.nlm.nih.gov/pubmed/32316910 http://dx.doi.org/10.1186/s12872-020-01474-5 |
Ejemplares similares
-
Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015) -
Coronary Stents in Patients with ST-Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention
por: Ahmed, Khurshid, et al.
Publicado: (2012) -
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zhu, Yi, et al.
Publicado: (2022) -
Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
por: Kurogi, Kazumasa, et al.
Publicado: (2019) -
Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention
for myocardial infarction
por: Vakili, Hossein, et al.
Publicado: (2013)